Nomogram to predict duration of clinical benefit from nivolumab in platinum resistant, recurrent/metastatic head and neck squamous cell carcinoma.
Journal of Clinical Oncology（2022）
Key words
nivolumab,squamous cell carcinoma,recurrent/metastatic head,platinum
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined